BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu Y, Zhao M, Wang J, Tang H, Wang B, Xiao F, Liu L, Zhang Y, Zhou A, Wang C, Wei W. Absorption and efflux characteristics of CP-25 in plasma and peripheral blood mononuclear cells of rats by UPLC-MS/MS. Biomedicine & Pharmacotherapy 2018;108:1651-7. [DOI: 10.1016/j.biopha.2018.09.156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang BJ, Wang YY, Jia CY, Li SS, Wang XW, Xu Y, Chen AY, Xu HP, Wang C, Yang ZY, Wei W, Chang Y. Paeoniflorin-6'-o-benzene sulfonate ameliorates the progression of adjuvant-induced arthritis by inhibiting the interaction between Ahr and GRK2 of fibroblast-like synoviocytes. Int Immunopharmacol 2022;108:108678. [PMID: 35364431 DOI: 10.1016/j.intimp.2022.108678] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wei X, Wu Y, Tang H, Wang B, Wang Y, Sun W, Asenso J, Xiao F, Wang C. CP-25 ameliorates methotrexate induced nephrotoxicity via improving renal apoptosis and methotrexate excretion. J Pharmacol Sci 2021;146:21-8. [PMID: 33858651 DOI: 10.1016/j.jphs.2021.02.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yang XZ, Wei W. CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases. Acta Pharmacol Sin 2020;41:1387-94. [PMID: 32884075 DOI: 10.1038/s41401-020-00510-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Asenso J, Yu J, Xiao F, Zhao M, Wang J, Wu Y, Wang C, Wei W. Methotrexate improves the anti-arthritic effects of Paeoniflorin-6'-O-benzene sulfonate by enhancing its pharmacokinetic properties in adjuvant-induced arthritis rats. Biomedicine & Pharmacotherapy 2019;112:108644. [DOI: 10.1016/j.biopha.2019.108644] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
5 Zhang J, Liu Y, Long M, Li J, Zhao W, Su Q. Inhibitory effect of CP-25 on intimal formation and vascular hyperplasia via suppression of GRK2/ERK1/2/EVI1 signaling. Arch Biochem Biophys 2020;694:108601. [PMID: 32980350 DOI: 10.1016/j.abb.2020.108601] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Tang H, Wu YJ, Xiao F, Wang B, Asenso J, Wang Y, Sun W, Wang C, Wei W. Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis. Biomed Pharmacother 2019;119:109432. [PMID: 31521892 DOI: 10.1016/j.biopha.2019.109432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]